tiprankstipranks
BioStem Technologies (BSEM)
OTHER OTC:BSEM
US Market
BSEM
BioStem Technologies
RESEARCH TOOLSreports

BioStem Technologies (BSEM) Income Statement

275 Followers

BioStem Technologies Income Statement

Last quarter (Q4 2025), BioStem Technologies's total revenue was $-84.82M, a decrease of -216.94% from the same quarter last year. In Q4, BioStem Technologies's net income was $-11.26M. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 47.48M$ 301.83M$ 16.69M$ 6.88M$ 4.34M
Gross Profit
$ 44.22M$ 287.86M$ 15.42M$ 5.99M$ 2.87M
Operating Expenses
$ 44.91M$ 256.66M$ 23.20M$ 10.67M$ 4.47M
Depreciation and Amortization
$ 219.42K$ 293.22K$ 229.02K$ 243.42K$ 283.90K
EBITDA
$ -469.73K$ 31.49M$ -7.55M$ -6.52M$ -602.00K
Operating Income
$ -689.15K$ 31.20M$ -7.78M$ -4.68M$ -1.61M
Other Income/Expenses
$ 299.50K$ -587.22K$ -704.01K$ -2.55M$ 193.93K
Pretax Income
$ -389.65K$ 30.61M$ -8.48M$ -7.11M$ -1.41M
Net Income
$ -6.58M$ 31.88M$ -8.48M$ -7.07M$ -1.45M
Per Share Metrics
Basic EPS
$ -0.39$ 1.95$ -0.62$ -0.62$ -0.12
Diluted EPS
$ -0.39$ 1.47$ -0.62$ -0.62$ -0.12
Weighted Average Shares Outstanding
 16.73M 16.37M 13.71M 11.41M 11.69M
Weighted Average Shares Outstanding (Diluted)
 16.73M 21.70M 13.71M 11.41M 11.69M
Currency in USD

BioStem Technologies Earnings and Revenue History